Page 8 - Research Comment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Research Comment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Research Comment Today - Breaking & Trending Today

Original-Research: Advanced Blockchain AG (von GBC AG):

Published: March 10, 2022

^ Original-Research: Advanced Blockchain AG - von GBC AG Einstufung von GBC AG zu Advanced Blockchain AG Unternehmen: Advanced Blockchain AG ISIN: DE000A0M93V6 Anlass der Studie: Research Comment Letzte Ratingänderung: Analyst: Julien Desrosiers, Matthias Greiffenberger, Felix Haugg Advanced Blo...

Source: boersennews.de

Investegate |Cogia AG Announcements | Cogia AG: Original-Research: Cogia AG (von GBC AG): BUY

Published: February 2, 2022

Investegate announcements from Cogia AG, Original-Research: Cogia AG (von GBC AG): BUY

Source: investegate.co.uk

Related Topics:

Felix Haugg Matthias Greiffenberger Research Comment Einen Katalog Investegate Announcements Investegate Company Announcements Ogia Ag Qs And Eqs

Investegate |HAEMATO AG Announcements | HAEMATO AG: Original-Research: HAEMATO AG (von GBC AG): Buy

Published: January 28, 2022

Investegate announcements from HAEMATO AG, Original-Research: HAEMATO AG (von GBC AG): Buy

Source: investegate.co.uk

Related Topics:

South Korea South Korean Marcel Goldmann Pharm Gmb Huons Biopharma Cosmin Filker Patrick Brenske Research Comment Einen Katalog Investegate Announcements Investegate Company Announcements Haemato Ag Qs And Eqs

Original-Research: HAEMATO AG (von GBC AG): Buy

Published: January 28, 2022

^ Original-Research: HAEMATO AG - von GBC AG Einstufung von GBC AG zu HAEMATO AG Unternehmen: HAEMATO AG ISIN: DE000A289VV1 Anlass der Studie: Research Comment Empfehlung: Buy Kursziel: 50.10 EUR Kursziel auf Sicht von: 31.12.2022 Letzte Ratingänderung: Analyst: Cosmin Filker; Marcel Goldmann PC...

Source: boersennews.de

Related Topics:

South Korea South Korean Marcel Goldmann Cosmin Filker Patrick Brenske Research Comment Einen Katalog

Original-Research: Defence Therapeutics Inc. (von GBC AG): -

Published: January 24, 2022

Original-Research: Defence Therapeutics Inc. - von GBC AG Einstufung von GBC AG zu Defence Therapeutics Inc. Unternehmen: Defence Therapeutics Inc. ISIN: CA24463V1013 Anlass der Studie: Research

Source: finanznachrichten.de

Related Topics:

Julien Desrosiers Cosmin Filker Sebastien Plouffe Sarkis Meterissian Simon Beaudoin Moutih Rafei Research Watchlist Defence Therapeutics Inc Innovation Centre University Of Alberta Breast Center Research Comment Head Of The Tumor Site Group Drug Development Defence Therapeutics Investment Advisor Tumor Site Group Innovation Centre Initial Coverage Einen Katalog

Page 9 Page 10 Page 11 Page 12